NEWS and OPINIONS
Scientists create “smart” DNA drug that targets cancer cells with extreme precision
By Université de Genève - Science Daily - Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers, preventing...
Patient deaths prompt concern over regenerative care not covered by insurance
By The Japan Times - A series of fatal accidents and regulatory violations involving regenerative treatments not covered by insurance have occurred in Japan, prompting health authorities to review related systems. Regenerative medicine, which uses cells or genes to...
Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
By Tristan Manalac - BIoSpace - The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence. After hitting a historic low in 2025—only eight biotechs went public, as per a BioSpace...
Clinical trial tests new cell therapy to manage kidney transplant rejection
By University of Wisconsin School of Medicine and Public Health - A first-of-its-kind clinical trial at the Program for Advanced Cell Therapy will examine a new method to manage kidney rejection following transplant. The Program for Advanced Cell Therapy, or PACT, a...
Scientists Discover Hidden “Footprint of Death” That Could Transform How We Fight Disease
By La Trobe University - SciTechDaily - Scientists have uncovered a previously unknown feature of cell death that reshapes how the immune system identifies and clears dying cells. Scientists at La Trobe University have identified a previously unknown way viruses may...
Nobel Prize winners face new loss in bid for US CRISPR patents
By Blake Brittain - Reuters News - March 27 (Reuters) - A U.S. Patent Office tribunal has ruled against Nobel Prize-winning scientists Jennifer Doudna and Emmanuelle Charpentier for a second time in their dispute with the Broad Institute, a joint venture of Harvard...
After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse
by Roswell Park Comprehensive Cancer Center - MedicalXPress - Results of a Phase I clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a lower risk of relapse and lower rates of graft-versus-host disease when they receive...
UCLA researchers receive $13.9 million CIRM grant to identify drug targets for autism and schizophrenia using human stem cell models
By Tiare Dunlap - UCLA Health - A team of researchers led by UCLA’s Dr. Daniel Geschwind has received a $13.9 million grant from the California Institute for Regenerative Medicine to use human stem cell-based models to uncover the molecular and cellular mechanisms...
RNA-guided CRISPR system activates gene expression
by Alisha Willett, Purdue University - PHYS.ORG - In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally evolved gene-editing system that can activate genes, offering an advantage over existing CRISPR...